Clopenthixol

Clopenthixol is a typical antipsychotic medication belonging to the class of thioxanthene derivatives. It is primarily used in the treatment of schizophrenia and other psychotic disorders. Clopenthixol is known for its efficacy in managing symptoms such as delusions, hallucinations, and thought disorders.
Pharmacology[edit]
Clopenthixol acts as an antagonist at various neurotransmitter receptors, including the dopamine D2 receptors, which is believed to contribute to its antipsychotic effects. By blocking these receptors, clopenthixol reduces the overactivity of dopamine pathways in the brain, which is a characteristic feature of psychotic disorders.
Clinical Use[edit]
Clopenthixol is used in the management of acute and chronic psychoses, particularly in patients with schizophrenia. It is available in different formulations, including oral tablets and long-acting injectable forms, which provide flexibility in treatment regimens. The choice of formulation depends on the clinical scenario and patient compliance.
Dosage and Administration[edit]
The dosage of clopenthixol varies depending on the formulation and the severity of the condition being treated. Oral doses are typically administered daily, while the injectable form may be given every two to four weeks. It is important to adjust the dose based on the patient's response and tolerance to the medication.
Side Effects[edit]
Common side effects of clopenthixol include sedation, dry mouth, constipation, and orthostatic hypotension. Like other typical antipsychotics, it may also cause extrapyramidal symptoms such as tremor, rigidity, and akathisia. Long-term use can lead to tardive dyskinesia, a potentially irreversible movement disorder.
Mechanism of Action[edit]
Clopenthixol primarily exerts its effects by blocking dopamine D2 receptors in the brain. This action reduces the positive symptoms of schizophrenia, such as hallucinations and delusions. Additionally, clopenthixol has some affinity for other receptors, including serotonin and histamine receptors, which may contribute to its side effect profile.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian